Telmisartan impedes JEV infection predominately via AT1/PPARγ axis
Ankita Datey, Sanchari Chatterjee, Soumyajit Ghosh, Pawan Kumar, Saikat De, Udvas Ghorai, Debasish Hota, Bharat Bhusan Subudhi, Soma Chattopadhyay
This study shows Telmisartan reduces JEV infection in vitro and in vivo by targeting the AT1/PPARγ axis, with significant anti-inflammatory effects.
Microbiology Spectrum · Aug 14, 2025Peer-reviewedMicrobiology